Literature DB >> 4049733

Modification of membrane permeability during Semliki Forest virus infection.

A Muñoz, J L Castrillo, L Carrasco.   

Abstract

Modification of membrane permeability has been analyzed in Semliki Forest virus (SFV)-infected cells by means of translation inhibitors not permeable to normal cells. A higher inhibition of protein synthesis in the infected cells is only observed with those antibiotics that do not easily pass the cell membrane, but not with others, permeable to cells, such as anisomycin, cycloheximide, trichodermin, etc. It does not, therefore, seem that the suggestion of M. A. Gray, K. J. Micklem, and C. A. Pasternak [Eur. J. Biochem. 135, 299-302, (1983)] that protein synthesis in virus-infected cells is more susceptible to translation inhibitors in general is correct. Both low- and high-molecular weight compounds enter the cell very early during SFV infection. This permeabilization is blocked by compounds known to increase the pH of coated vesicles, such as NH4Cl and chloroquine. Inhibition of energy production by means of N3Na and 2'-deoxyglucose also blocks this process. The optimal external pH for this early permeabilization is around 7-8. Acidic pH inhibits the entry of these impermeant antibiotics promoted by SFV. Analysis of 86Rb+ content in SFV-infected HeLa cells also indicates that a drastic decline in this cation takes place, in agreement with previous findings, but disagreeing with the previous results. A parallel between the decrease in this cation and the blockade of protein synthesis is apparent, throughout the course of infection. In addition to the early permeabilization that takes place during virus entry, increased entry of hygromycin B and alpha-sarcin also occurs in SFV-infected cells from 2 to 3 hr postinfection, but not when late viral replication is blocked by means of interferon treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049733     DOI: 10.1016/0042-6822(85)90004-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleolytic toxin restrictocin and its expression in Aspergillus nidulans: the leader sequence protects producing strains from suicide.

Authors:  B Lamy; J Davies
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

3.  Polysaccharides as antiviral agents: antiviral activity of carrageenan.

Authors:  M E González; B Alarcón; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

4.  Killing of Burkitt-lymphoma-derived Daudi cells by ultraviolet-inactivated vaccinia virus.

Authors:  L Grunwald-Beard; H Gamliel; G Parag; S Vedantham; Z Zakay-Rones
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Hygromycin B inhibits synthesis of murine coronavirus RNA.

Authors:  G Macintyre; D E Woods; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

6.  Translocation of alpha-sarcin across the lipid bilayer of asolectin vesicles.

Authors:  M Oñaderra; J M Mancheño; M Gasset; J Lacadena; G Schiavo; A Martínez del Pozo; J G Gavilanes
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

7.  Kinetic study of the cytotoxic effect of alpha-sarcin, a ribosome inactivating protein from Aspergillus giganteus, on tumour cell lines: protein biosynthesis inhibition and cell binding.

Authors:  J Turnay; N Olmo; A Jiménez; M A Lizarbe; J G Gavilanes
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

Review 8.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

9.  The effect of a mesogenic and a lentogenic Newcastle disease virus strain on Burkitt lymphoma Daudi cells.

Authors:  Y Tzadok-David; M Metzkin-Eizenberg; Z Zakay-Rones
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Sensitivity of Burkitt lymphoma Daudi cells to inactive influenza virus.

Authors:  Y Shlomi; Z Zakay-Rones
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.